Changing patterns in medication use with increasing probability of death for older medicare beneficiaries

Journal of the American Geriatrics Society

Volumn 58, Issue 8, 2010, Pages 1549-1555

  Shaffer, Thomas ^a   Simoni Wastila, Linda ^a   Toler, Wendy ^a   Stuart, Bruce ^a   Doshi, Jalpa A ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

end of life prescribing; Medicare; prescription medications

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CITALOPRAM; CODEINE; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LORAZEPAM; NARCOTIC ANALGESIC AGENT; OXYCODONE; TRAZODONE;

AGED; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; ELDERLY CARE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INSOMNIA; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; OSTEOPOROSIS; PAIN; PRESCRIPTION;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BONE DENSITY CONSERVATION AGENTS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HEALTH SURVEYS; HOSPICE CARE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPNOTICS AND SEDATIVES; MALE; MEDICARE; MORTALITY; UNITED STATES;

EID: 77955252782     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02957.x     Document Type: Article

References (32)

1. Scitovsky AA. "The high cost of dying": What do the data show? Milbank Mem Fund Q Health Soc 1984 62 : 591 608.
2. Lubitz JD, Riley GF. Trends in Medicare payments in the last year of life. N Engl J Med 1993 328 : 1092 1096.
3. Lubitz J, Prihoda R. The use and costs of Medicare services in the last 2 years of life. Health Care Financ Rev 1984 5 : 117 131.
4. Buntin MB, Huskamp H. What is known about the economics of end-of-life care for medicare beneficiaries? Gerontologist 2002 42 (Spec No 3) : 40 48.
5. Barnato AE, McClellan MB, Kagay CR et al. Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life. Health Serv Res 2004 39 : 363 375.
6. Coulson NE, Terza JV, Neslusan CA et al. Estimating the moral-hazard effect of supplemental medical insurance in the demand for prescription drugs by the elderly. Am Econ Rev 1995 85 : 122 126.
7. Stuart B, Coulson NE. Use of outpatient drugs as death approaches. Health Care Financ Rev 1994 15 : 63 82.
8. Fahlman C, Lynn J, Doberman D et al. Prescription drug spending for Medicare+Choice beneficiaries in the last year of life. J Palliat Med 2006 9 : 884 893.
9. Hoover DR, Crystal S, Kumar R et al. Medical expenditures during the last year of life: Findings from the 1992-1996 Medicare current beneficiary survey. Health Serv Res 2002 37 : 1625 1642.
10. Bookwalter TC, Rabow MW, McPhee SJ. Content on end-of-life care in major pharmacy textbooks. Am J Health Syst Pharm 2003 60 : 1246 1250.
11. Carron AT, Lynn J, Keaney P. End-of-life care in medical textbooks. Ann Intern Med 1999 130 : 82 86.
12. Wu HY, Malik FA, Higginson IJ. End of life content in geriatric textbooks: What is the current situation? BMC Palliat Care 2006 5 : 5.
13. Mast KR, Salama M, Silverman GK et al. End-of-life content in treatment guidelines for life-limiting diseases. J Palliat Med 2004 7 : 754 773.
14. Tieman J, Sladek R, Currow D. Changes in the quantity and level of evidence of palliative and hospice care literature: The last century. J Clin Oncol 2008 26 : 5679 5683.
15. Qaseem A, Snow V, Shekelle P et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2008 148 : 141 146.
16. Bain KT, Holmes HM, Beers MH et al. Discontinuing medications: A novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 2008 56 : 1946 1952.
17. Lee SP, Bain KT, Maio V. Appropriate discontinuation of medications at the end of life: A need to establish consensus criteria. Am J Med Qual 2007 22 : 393 394.
18. Riechelmann RP, Krzyzanowska MK, Zimmermann C. Futile medication use in terminally ill cancer patients. Support Care Cancer 2009 17 : 745 748.
19. Silveira MJ, Kazanis AS, Shevrin MP. Statins in the last six months of life: A recognizable, life-limiting condition does not decrease their use. J Palliat Med 2008 11 : 685 693.
20. Eppig FJ, Chulis GS. Matching MCBS (Medicare Current Beneficiary Survey) and Medicare data: The best of both worlds. Health Care Financ Rev 1997 18 : 211 229.
21. Eppig FJ, Poisal JA. Measuring the health status of Medicare beneficiaries: 1995. Health Care Financ Rev 1997 18 : 125 131.
22. De Lima L. International Association for Hospice and Palliative Care list of essential medicines for palliative care. Ann Oncol 2007 18 : 395 399. (Pubitemid 46323113)
23. IAHPC list of essential medicines for palliative care [on-line]. Available at Accessed April 12, 2009.
24. Currow DC, Stevenson JP, Abernethy AP et al. Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007 55 : 590 595.
25. Holmes HM. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther 2009 85 : 103 107.
26. Holmes HM, Hayley DC, Alexander GC et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006 166 : 605 609.
27. Holmes HM, Sachs GA, Shega JW et al. Integrating palliative medicine into the care of persons with advanced dementia: Identifying appropriate medication use. J Am Geriatr Soc 2008 56 : 1306 1311.
28. Stevenson J, Abernethy AP, Miller C et al. Managing comorbidities in patients at the end of life. BMJ 2004 329 : 909 912.
29. Stevenson JP, Currow DC, Abernethy AP. Frameworks for prescribing in comorbid illness. J Pain Symptom Manage 2007 34 : 117 118.
30. SUPPORT-Principal-Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 1995 274 : 1591 1598.
31. Tulsky JA. Beyond advance directives: Importance of communication skills at the end of life. JAMA 2005 294 : 359 365.
32. Farber NJ, Simpson P, Salam T et al. Physicians' decisions to withhold and withdraw life-sustaining treatment. Arch Intern Med 2006 166 : 560 564.